Cannabis CEO To SEC Attorney: ‘Eat S—‘
Idrasil, a cannabis-based tablet aimed at the medical community, is at the center of a long-running lawsuit filed by the Securities and Exchange Commission against a California cannabis company.
The SEC alleges fraud and investor losses in the lawsuit, filed Sept. 28, 2021 against C3 International and its husband-and-wife management team, and accuses the defendants of raising about $2 million from more than 40 investors by misrepresenting the business and its cannabis pill ā and selling stock in the company without filing a securities and registration statement.
C3 International CEO Steele Smith III said the lawsuit represents an attack by the federal government on a natural alternative to opioid pain medication that threatens the interests of the pharmaceutical industry.
“Eat sā d(er)ick. You reside in hell,” Smith wrote in a June 15, 2023 email entered in the court record, followed by a middle finger emoji. The email came in reply to a message from SEC attorney Derek Bentsen to Smith and his wife Theresa Smith, C3’s president, regarding scheduling in the case. The Smiths are representing themselves in the …